Nomura Holdings’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15M Buy
238,708
+132,589
+125% +$10.6M 0.04% 324
2025
Q4
$10.1M Sell
106,119
-159,293
-60% -$15.6M 0.01% 513
2025
Q3
$25.9M Buy
+265,412
New +$27.5M 0.04% 262
2025
Q2
Sell
-65,486
Closed -$6.63M 1501
2025
Q1
$6.61M Buy
65,486
+14,629
+29% +$1.47M 0.01% 603
2024
Q4
$4.54M Buy
50,857
+24,768
+95% +$2.18M 0.01% 807
2024
Q3
$2.19M Sell
26,089
-81,823
-76% -$6.45M 0.01% 919
2024
Q2
$8.31M Sell
107,912
-4,874
-4% -$357K 0.02% 511
2024
Q1
$7.72M Sell
112,786
-98,177
-47% -$6.31M 0.02% 515
2023
Q4
$12.2M Buy
210,963
+89,963
+74% +$4.8M 0.03% 390
2023
Q3
$6.39M Sell
121,000
-112,808
-48% -$5.92M 0.02% 458
2023
Q2
$12.6M Buy
233,808
+224,997
+2,554% +$11.8M 0.03% 287
2023
Q1
$441K Sell
8,811
-10,460
-54% -$493K ﹤0.01% 1151
2022
Q4
$891K Buy
19,271
+14,271
+285% +$618K ﹤0.01% 863
2022
Q3
$194K Sell
5,000
-24,728
-83% -$992K ﹤0.01% 1255
2022
Q2
$1.13M Sell
29,728
-27,107
-48% -$1.1M ﹤0.01% 927
2022
Q1
$2.56M Buy
56,835
+12,466
+28% +$540K 0.01% 815
2021
Q4
$1.89M Sell
44,369
-24,166
-35% -$1.02M ﹤0.01% 1020
2021
Q3
$3M Buy
68,535
+1,760
+3% +$77.9K 0.01% 793
2021
Q2
$2.85M Buy
66,775
+36,641
+122% +$1.54M 0.01% 748
2021
Q1
$1.16M Sell
30,134
-51,415
-63% -$1.95M ﹤0.01% 1038
2020
Q4
$2.93M Sell
81,549
-831,786
-91% -$30M ﹤0.01% 716
2020
Q3
$34.9M Buy
913,335
+847,838
+1,294% +$32.7M 0.08% 156
2020
Q2
$2.3M Buy
+65,497
New +$2.36M 0.01% 537
2019
Q4
Sell
-120,058
Closed -$4.83M 1108
2019
Q3
$4.83M Sell
120,058
-49,034
-29% -$2.08M 0.02% 471
2019
Q2
$7.25M Sell
169,092
-151,466
-47% -$5.83M 0.03% 387
2019
Q1
$12.4M Sell
320,558
-53,129
-14% -$2.03M 0.05% 267
2018
Q4
$13.2M Buy
373,687
+330,820
+772% +$12M 0.05% 265
2018
Q3
$1.67M Sell
42,867
-150,506
-78% -$5.26M 0.01% 769
2018
Q2
$6.32M Sell
193,373
-372,758
-66% -$11.2M 0.02% 458
2018
Q1
$15.5K Buy
566,131
+267,419
+90% +$7.27M 0.03% 308
2017
Q4
$7.42M Buy
298,712
+228,901
+328% +$6.31M 0.01% 523
2017
Q3
$2.03M Sell
69,811
-33,799
-33% -$933K ﹤0.01% 845
2017
Q2
$2.87M Buy
+103,610
New +$2.75M 0.01% 732
2017
Q1
Sell
-74,955
Closed -$1.62M 1302
2016
Q4
$1.62M Buy
74,955
+64,855
+642% +$1.42M ﹤0.01% 929
2016
Q3
$240K Buy
+10,100
New +$241K ﹤0.01% 1044
2016
Q2
Sell
-11,411
Closed -$214K 1264
2016
Q1
$214K Sell
11,411
-29,997
-72% -$527K ﹤0.01% 1211
2015
Q4
$764K Sell
41,408
-309
-0.7% -$5.54K ﹤0.01% 887
2015
Q3
$673K Buy
41,717
+2,166
+5% +$37K ﹤0.01% 870
2015
Q2
$684K Buy
39,551
+21,968
+125% +$393K ﹤0.01% 1147
2015
Q1
$306K Sell
17,583
-125,451
-88% -$1.98M ﹤0.01% 1322
2014
Q4
$1.89M Buy
143,034
+107,530
+303% +$1.37M 0.01% 1065
2014
Q3
$424K Sell
35,504
-162,741
-82% -$2.05M ﹤0.01% 1932
2014
Q2
$2.53M Sell
198,245
-113,397
-36% -$1.47M ﹤0.01% 1011
2014
Q1
$4.21M Buy
311,642
+159,806
+105% +$2.1M ﹤0.01% 821
2013
Q4
$1.82M Sell
151,836
-132,582
-47% -$1.57M 0.01% 747
2013
Q3
$3.35M Buy
284,418
+89,663
+46% +$970K 0.02% 633
2013
Q2
$1.81M Buy
+194,755
New +$1.65M 0.01% 729

Other funds holding BSX

Nomura Holdings's BSX Position: Q1 2026 in Review

Nomura Holdings increased its Boston Scientific (BSX) stake by 125% in Q1 2026, buying an estimated $10.6M and bringing the position to 238,708 shares worth $15M. The position accounts for 0.04% of the portfolio, ranked #324.

Nomura Holdings first reported a position in BSX in Q2 2013 and has held it in 47 quarters since. The position peaked at $34.9M in Q3 2020. 1,672 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Nomura Holdings held 238,708 shares of Boston Scientific worth $15M as of Q1 2026.
  • Nomura Holdings bought 132,589 Boston Scientific shares in Q1 2026, an estimated $10.6M.
  • Boston Scientific made up 0.04% of Nomura Holdings's portfolio in Q1 2026, its #324 holding.
  • Nomura Holdings first reported a position in Boston Scientific in Q2 2013 and has held it in 47 quarters since.
  • Nomura Holdings's Boston Scientific position peaked at $34.9M in Q3 2020.
  • 1,672 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.